MedPath

rTMS for Auditory Hallucinations Guided by Magnetoencephalography

Not Applicable
Recruiting
Conditions
Schizophrenia
Interventions
Device: rTMS and MEG for auditory hallucinations via self controlled clinical trials
Registration Number
NCT05598450
Lead Sponsor
Shanghai Mental Health Center
Brief Summary

rTMS and MEG for auditory hallucinations via self controlled clinical trials. Repetitive transcranial magnetic stimulation (rTMS) can increase or decrease cortical excitability in patients with psychosis (such as schizophrenia). Here, we conducted an open clinical trial on 60 schizophrenics with auditory hallucinations. We searched for targets through magnetoencephalography and then intervened to prove that rTMS guided by magnetoencephalography is effective for auditory hallucinations.

Detailed Description

Before intervention, each patient was scheduled to collect three magnetoencephalogram data sessions. Apply MEG technology to calculate possible locations and determine three intervention targets. Pseudo stimulation in the first week, 5-day intervention, 3 targets per day, each target for 23 minutes, with a 30 minute interval between each target. Evaluate the scale after the first week of pseudo stimulation. Week 2-4 real stimulation, intervention 5 days a week, 3 targets per day, each target for 23 minutes, with a 30 minute interval between each target. After the end of the fourth week, evaluate the scale. And follow-up evaluations will be conducted on the 7th, 14th, 30th, 60th, and 90th days after the intervention.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Schizophrenia with auditory hallucinations was diagnosed by DSM-IV, AHRS >12, Take sufficient antipsychotics for at least 1 month.
Exclusion Criteria
  • current pregnancy, major medical illness affecting the central nervous system, significant neurologic disorders, intake of drugs including supplements like essential fatty acids that influence prostaglandins or niacin skin flush flash pathway metabolism, a history of suicide risk, or alcohol or drug abuse.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
schizophrenia patients with auditory hallucinationsrTMS and MEG for auditory hallucinations via self controlled clinical trialsFor schizophrenia patients with auditory hallucinations, rTMS+MEG for implementation intervention
Primary Outcome Measures
NameTimeMethod
Reduction rate of AHRS scaleOne month

Reduction rate of AHRS scale (the minimum is 0, maximum value is 47, and higher scores mean a worse outcome)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Shanghai Mental Health Center

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath